Yonekura K - Search Results

1

Outlines of the Japanese guidelines for the management of primary cutaneous lymphomas 2020.

Ohtsuka M, Hamada T, Miyagaki T, Shimauchi T, Yonekura K, Kiyohara E, Fujita H, Izutsu K, Okuma K, Kawai K, Koga H, Sugaya M. Ohtsuka M, et al. Among authors: yonekura k. J Dermatol. 2021 Feb;48(2):e49-e71. doi: 10.1111/1346-8138.15707. Epub 2020 Nov 27. J Dermatol. 2021. PMID: 33245165

2

Cutaneous-type adult T-cell leukemia/lymphoma does not primarily show deletion of NAV3 gene.

Kawai K, Uchida Y, Yonekura K, Virtanen S, Tähtinen M, Krohn K, Ranki A, Kanekura T. Kawai K, et al. Among authors: yonekura k. J Invest Dermatol. 2010 Jan;130(1):316-8. doi: 10.1038/jid.2009.230. J Invest Dermatol. 2010. PMID: 19626031 Free article. No abstract available.

3

Successful treatment of metastatic extramammary Paget's disease with S-1 and docetaxel combination chemotherapy.

Matsushita S, Yonekura K, Mera K, Kawai K, Kanekura T. Matsushita S, et al. Among authors: yonekura k. J Dermatol. 2011 Oct;38(10):996-8. doi: 10.1111/j.1346-8138.2010.01149.x. Epub 2011 Feb 1. J Dermatol. 2011. PMID: 21972953 No abstract available.

4

Indication for random skin biopsy for the diagnosis of intravascular large B cell lymphoma.

Higashi Y, Kawai K, Yonekura K, Takeda K, Kanzaki T, Utsunomiya A, Kanekura T. Higashi Y, et al. Among authors: yonekura k. Dermatology. 2012;224(1):46-50. doi: 10.1159/000336885. Epub 2012 Mar 13. Dermatology. 2012. PMID: 22414723

5

Guidelines for the management of cutaneous lymphomas (2011): a consensus statement by the Japanese Skin Cancer Society - Lymphoma Study Group.

Sugaya M, Hamada T, Kawai K, Yonekura K, Ohtsuka M, Shimauchi T, Tokura Y, Nozaki K, Izutsu K, Suzuki R, Setoyama M, Nagatani T, Koga H, Tani M, Iwatsuki K. Sugaya M, et al. Among authors: yonekura k. J Dermatol. 2013 Jan;40(1):2-14. doi: 10.1111/j.1346-8138.2012.01639.x. Epub 2012 Aug 20. J Dermatol. 2013. PMID: 22900999

6

Effect of anti-CCR4 monoclonal antibody (mogamulizumab) on adult T-cell leukemia-lymphoma: cutaneous adverse reactions may predict the prognosis.

Yonekura K, Kanzaki T, Gunshin K, Kawakami N, Takatsuka Y, Nakano N, Tokunaga M, Kubota A, Takeuchi S, Kanekura T, Utsunomiya A. Yonekura K, et al. J Dermatol. 2014 Mar;41(3):239-44. doi: 10.1111/1346-8138.12419. J Dermatol. 2014. PMID: 24628073 Clinical Trial.

7

Human T-lymphotropic virus type I proviral loads in patients with adult T-cell leukemia-lymphoma: Comparison between cutaneous type and other subtypes.

Yonekura K, Utsunomiya A, Seto M, Takatsuka Y, Takeuchi S, Tokunaga M, Kubota A, Takeda K, Kanzaki T, Uchida Y, Kawai K, Kanekura T. Yonekura K, et al. J Dermatol. 2015 Dec;42(12):1143-8. doi: 10.1111/1346-8138.13004. Epub 2015 Jun 30. J Dermatol. 2015. PMID: 26134467

8

Darier's Disease with Esophageal Involvement.

Baba A, Yonekura K, Takeda K, Kawai K, Kanekura T. Baba A, et al. Among authors: yonekura k. Acta Dermatovenerol Croat. 2015;23(3):218-9. Acta Dermatovenerol Croat. 2015. PMID: 26476908 No abstract available.

9

Phase I/II study of the oral retinoid X receptor agonist bexarotene in Japanese patients with cutaneous T-cell lymphomas.

Hamada T, Sugaya M, Tokura Y, Ohtsuka M, Tsuboi R, Nagatani T, Tani M, Setoyama M, Matsushita S, Kawai K, Yonekura K, Yoshida T, Saida T, Iwatsuki K. Hamada T, et al. Among authors: yonekura k. J Dermatol. 2017 Feb;44(2):135-142. doi: 10.1111/1346-8138.13542. Epub 2016 Aug 20. J Dermatol. 2017. PMID: 27543197 Clinical Trial.

10

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial.

Kim YH, Bagot M, Pinter-Brown L, Rook AH, Porcu P, Horwitz SM, Whittaker S, Tokura Y, Vermeer M, Zinzani PL, Sokol L, Morris S, Kim EJ, Ortiz-Romero PL, Eradat H, Scarisbrick J, Tsianakas A, Elmets C, Dalle S, Fisher DC, Halwani A, Poligone B, Greer J, Fierro MT, Khot A, Moskowitz AJ, Musiek A, Shustov A, Pro B, Geskin LJ, Dwyer K, Moriya J, Leoni M, Humphrey JS, Hudgens S, Grebennik DO, Tobinai K, Duvic M; MAVORIC Investigators. Kim YH, et al. Lancet Oncol. 2018 Sep;19(9):1192-1204. doi: 10.1016/S1470-2045(18)30379-6. Epub 2018 Aug 9. Lancet Oncol. 2018. PMID: 30100375 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

233 results

Search Page